+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veloxis Pharmaceuticals A/S - logo

Veloxis Pharmaceuticals is a commercial-stage specialty pharmaceutical company that operates in Europe and the United States. Veloxis’ products include tacrolimus extended-release tablets called Envarsus XR and MeltDose, which is designed to enhance the absorption and bioavailability of select orally administered drugs. The company was formerly known as LifeCycle Pharma A/S and changed its name to Veloxis Pharmaceuticals A/S in July 2011. Veloxis is based in Copenhagen, Denmark.

From
From
From
Immunosuppressant Drugs Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Immunosuppressant Drugs Market - Forecasts from 2022 to 2027

  • Report
  • August 2022
  • 145 Pages
  • Global
From
From
Vitiligo Therapeutics Market 2022-2026 - Product Thumbnail Image

Vitiligo Therapeutics Market 2022-2026

  • Report
  • June 2022
  • 120 Pages
  • Global
From
From
From
From
From
  • 17 Results (Page 1 of 1)
Loading Indicator